614 related articles for article (PubMed ID: 25988230)
1. Elevated expression levels of lysyl oxidases protect against aortic aneurysm progression in Marfan syndrome.
Busnadiego O; Gorbenko Del Blanco D; González-Santamaría J; Habashi JP; Calderon JF; Sandoval P; Bedja D; Guinea-Viniegra J; Lopez-Cabrera M; Rosell-Garcia T; Snabel JM; Hanemaaijer R; Forteza A; Dietz HC; Egea G; Rodriguez-Pascual F
J Mol Cell Cardiol; 2015 Aug; 85():48-57. PubMed ID: 25988230
[TBL] [Abstract][Full Text] [Related]
2. miR-29b participates in early aneurysm development in Marfan syndrome.
Merk DR; Chin JT; Dake BA; Maegdefessel L; Miller MO; Kimura N; Tsao PS; Iosef C; Berry GJ; Mohr FW; Spin JM; Alvira CM; Robbins RC; Fischbein MP
Circ Res; 2012 Jan; 110(2):312-24. PubMed ID: 22116819
[TBL] [Abstract][Full Text] [Related]
3. Aortopathy in a Mouse Model of Marfan Syndrome Is Not Mediated by Altered Transforming Growth Factor β Signaling.
Wei H; Hu JH; Angelov SN; Fox K; Yan J; Enstrom R; Smith A; Dichek DA
J Am Heart Assoc; 2017 Jan; 6(1):. PubMed ID: 28119285
[TBL] [Abstract][Full Text] [Related]
4. Redox stress in Marfan syndrome: Dissecting the role of the NADPH oxidase NOX4 in aortic aneurysm.
Jiménez-Altayó F; Meirelles T; Crosas-Molist E; Sorolla MA; Del Blanco DG; López-Luque J; Mas-Stachurska A; Siegert AM; Bonorino F; Barberà L; García C; Condom E; Sitges M; Rodríguez-Pascual F; Laurindo F; Schröder K; Ros J; Fabregat I; Egea G
Free Radic Biol Med; 2018 Apr; 118():44-58. PubMed ID: 29471108
[TBL] [Abstract][Full Text] [Related]
5. Dimorphic effects of transforming growth factor-β signaling during aortic aneurysm progression in mice suggest a combinatorial therapy for Marfan syndrome.
Cook JR; Clayton NP; Carta L; Galatioto J; Chiu E; Smaldone S; Nelson CA; Cheng SH; Wentworth BM; Ramirez F
Arterioscler Thromb Vasc Biol; 2015 Apr; 35(4):911-7. PubMed ID: 25614286
[TBL] [Abstract][Full Text] [Related]
6. MMP-2 regulates Erk1/2 phosphorylation and aortic dilatation in Marfan syndrome.
Xiong W; Meisinger T; Knispel R; Worth JM; Baxter BT
Circ Res; 2012 Jun; 110(12):e92-e101. PubMed ID: 22550139
[TBL] [Abstract][Full Text] [Related]
7. Enhanced caspase activity contributes to aortic wall remodeling and early aneurysm development in a murine model of Marfan syndrome.
Emrich FC; Okamura H; Dalal AR; Penov K; Merk DR; Raaz U; Hennigs JK; Chin JT; Miller MO; Pedroza AJ; Craig JK; Koyano TK; Blankenberg FG; Connolly AJ; Mohr FW; Alvira CM; Rabinovitch M; Fischbein MP
Arterioscler Thromb Vasc Biol; 2015 Jan; 35(1):146-54. PubMed ID: 25359856
[TBL] [Abstract][Full Text] [Related]
8. Regional changes in elastic fiber organization and transforming growth factor β signaling in aortas from a mouse model of marfan syndrome.
Howell DW; Popovic N; Metz RP; Wilson E
Cell Tissue Res; 2014 Dec; 358(3):807-19. PubMed ID: 25238995
[TBL] [Abstract][Full Text] [Related]
9. Differential expression of lysyl oxidases LOXL1 and LOX during growth and aging suggests specific roles in elastin and collagen fiber remodeling in rat aorta.
Behmoaras J; Slove S; Seve S; Vranckx R; Sommer P; Jacob MP
Rejuvenation Res; 2008 Oct; 11(5):883-9. PubMed ID: 18803461
[TBL] [Abstract][Full Text] [Related]
10. [Naringenin inhibits thoracic aortic aneurysm formation in mice with Marfan syndrome].
Li ZQ; Yu B; Cai ZY; Wang YB; Zhang X; Zhou B; Fang XH; Yu F; Fu Y; Sun JP; Li W; Kong W
Beijing Da Xue Xue Bao Yi Xue Ban; 2022 Oct; 54(5):896-906. PubMed ID: 36241232
[TBL] [Abstract][Full Text] [Related]
11. Anatomically specific reactive oxygen species production participates in Marfan syndrome aneurysm formation.
Emrich F; Penov K; Arakawa M; Dhablania N; Burdon G; Pedroza AJ; Koyano TK; Kim YM; Raaz U; Connolly AJ; Iosef C; Fischbein MP
J Cell Mol Med; 2019 Oct; 23(10):7000-7009. PubMed ID: 31402541
[TBL] [Abstract][Full Text] [Related]
12. Doxycycline delays aneurysm rupture in a mouse model of Marfan syndrome.
Xiong W; Knispel RA; Dietz HC; Ramirez F; Baxter BT
J Vasc Surg; 2008 Jan; 47(1):166-72; discussion 172. PubMed ID: 18178469
[TBL] [Abstract][Full Text] [Related]
13. Resveratrol Inhibits Aortic Root Dilatation in the Fbn1C1039G/+ Marfan Mouse Model.
Hibender S; Franken R; van Roomen C; Ter Braake A; van der Made I; Schermer EE; Gunst Q; van den Hoff MJ; Lutgens E; Pinto YM; Groenink M; Zwinderman AH; Mulder BJ; de Vries CJ; de Waard V
Arterioscler Thromb Vasc Biol; 2016 Aug; 36(8):1618-26. PubMed ID: 27283746
[TBL] [Abstract][Full Text] [Related]
14. Proteomics reveals Rictor as a noncanonical TGF-β signaling target during aneurysm progression in Marfan mice.
Parker SJ; Stotland A; MacFarlane E; Wilson N; Orosco A; Venkatraman V; Madrid K; Gottlieb R; Dietz HC; Van Eyk JE
Am J Physiol Heart Circ Physiol; 2018 Nov; 315(5):H1112-H1126. PubMed ID: 30004239
[TBL] [Abstract][Full Text] [Related]
15. Renal cystic disease in the Fbn1
Hibender S; Wanga S; van der Made I; Vos M; Mulder BJ; Balm R; de Vries CJ; de Waard V
Cardiovasc Pathol; 2019; 38():1-6. PubMed ID: 30359839
[TBL] [Abstract][Full Text] [Related]
16. Single-Cell Transcriptomic Profiling of Vascular Smooth Muscle Cell Phenotype Modulation in Marfan Syndrome Aortic Aneurysm.
Pedroza AJ; Tashima Y; Shad R; Cheng P; Wirka R; Churovich S; Nakamura K; Yokoyama N; Cui JZ; Iosef C; Hiesinger W; Quertermous T; Fischbein MP
Arterioscler Thromb Vasc Biol; 2020 Sep; 40(9):2195-2211. PubMed ID: 32698686
[TBL] [Abstract][Full Text] [Related]
17. Effects of Age, Sex, and Extracellular Matrix Integrity on Aortic Dilatation and Rupture in a Mouse Model of Marfan Syndrome.
Weiss D; Rego BV; Cavinato C; Li DS; Kawamura Y; Emuna N; Humphrey JD
Arterioscler Thromb Vasc Biol; 2023 Sep; 43(9):e358-e372. PubMed ID: 37470181
[TBL] [Abstract][Full Text] [Related]
18. Impact of Notch3 Activation on Aortic Aneurysm Development in Marfan Syndrome.
Jespersen K; Li C; Batra R; Stephenson CA; Harding P; Sestak K; Foley RT; Greene H; Meisinger T; Cook JR; Baxter BT; Xiong W
J Immunol Res; 2022; 2022():7538649. PubMed ID: 35211631
[TBL] [Abstract][Full Text] [Related]
19. NADPH oxidase 4 attenuates cerebral artery changes during the progression of Marfan syndrome.
Onetti Y; Meirelles T; Dantas AP; Schröder K; Vila E; Egea G; Jiménez-Altayó F
Am J Physiol Heart Circ Physiol; 2016 May; 310(9):H1081-90. PubMed ID: 26945079
[TBL] [Abstract][Full Text] [Related]
20. Altered tissue behavior of a non-aneurysmal descending thoracic aorta in the mouse model of Marfan syndrome.
Haskett D; Doyle JJ; Gard C; Chen H; Ball C; Estabrook MA; Encinas AC; Dietz HC; Utzinger U; Vande Geest JP; Azhar M
Cell Tissue Res; 2012 Jan; 347(1):267-77. PubMed ID: 22105919
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
